Evidence map›Paper›PMID 26978329›Full record

ArticleMolecules (Basel, Switzerland)2016

Phosphorylation of Akt by SC79 Prevents Iron Accumulation and Ameliorates Early Brain Injury in a Model of Experimental Subarachnoid Hemorrhage.

Shuangying Hao, Chuanhui Song, Longcheng Shang, Jiang Yu, Tong Qiao, Kuanyu Li

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shuangying HaoJiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China. shuangying9088@163.com.
Chuanhui SongJiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China. songchuanhui1016@hotmail.com.
Longcheng ShangJiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China. sjbslc@126.com.
Jiang YuDepartment of Vascular Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China. rickyjy@163.com.
Tong QiaoDepartment of Vascular Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China. qiaotongmail@aliyun.com.
Kuanyu LiJiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China. likuanyu@nju.edu.cn.
Nanjing University · CNNanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have demonstrated that activation of Akt may alleviate early brain injury (EBI) following subarachnoid hemorrhage (SAH). This study is undertaken to determine whether iron metabolism is involved in the beneficial effect of Akt activation after SAH. Therefore, we used a novel molecule, SC79, to activate Akt in an experimental Sprague-Dawley rat model of SAH. Rats were randomly divided into four groups as follows: sham, SAH, SAH + vehicle, SAH + SC79. The results confirmed that SC79 effectively enhanced the defense against oxidative stress and alleviated EBI in the temporal lobe after SAH. Interestingly, we found that phosphorylation of Akt by SC79 reduced cell surface transferrin receptor-mediated iron uptake and promoted ferroportin-mediated iron transport after SAH. As a result, SC79 administration diminished the iron content in the brain tissue. Moreover, the impaired Fe-S cluster biogenesis was recovered and loss of the activities of the Fe-S cluster-containing enzymes were regained, indicating that injured mitochondrial functions are restored to healthy levels. These findings suggest that disrupted iron homeostasis could contribute to EBI and Akt activation may regulate iron metabolism to relieve iron toxicity, further protecting neurons from EBI after SAH.

Indexed as

AcetatesAnimalsBenzopyransDisease Models, AnimalEnzyme ActivationIronIron-Sulfur ProteinsMaleNerve Tissue ProteinsNeuroprotective AgentsOxidative StressPhosphorylationProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleySubarachnoid HemorrhageAcetatesAKT activator SC79BenzopyransIronIron-Sulfur ProteinsNerve Tissue ProteinsNeuroprotective AgentsProto-Oncogene Proteins c-aktAkt phosphorylationFe-S cluster biogenesisiron homeostasisoxidative stressSC79subarachnoid hemorrhage

Identifiers

PMID26978329
PMCPMC6272957
OpenAlexW2293818241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.